Infectious complications of lung transplantation

Seminars in Respiratory and Critical Care Medicine

Volumn 17, Issue 2, 1996, Pages 167-171

  Fisher, James H ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; CYTOMEGALOVIRUS ANTIBODY; FLUCONAZOLE; GANCICLOVIR; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; PENTAMIDINE; TUBERCULIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; CANDIDA ALBICANS; CHEMOPROPHYLAXIS; CYTOMEGALOVIRUS INFECTION; DRUG HYPERSENSITIVITY; HUMAN; INFECTION RISK; INFECTIOUS COMPLICATION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ASPERGILLOSIS; LUNG TRANSPLANTATION; MYCOBACTERIOSIS; MYCOSIS; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; TUBERCULIN TEST;

EID: 0029881784     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1009885     Document Type: Review

References (36)

1. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990;11(2):291-300
2. Horvath J, Dummer S, Loyd J, et al. Infection in the transplanted and native lung after single lung transplantation. Chest 1993;104(3):681-5
3. Dummer JS, Montero CG, Griffith BP, et al. Infections in heart-lung transplant recipients. Transplantation 1986;41:725-9
4. Marelli D, Paul A, Nguyen DM, et al. The reversibility of impaired mucociliary function after lung transplantation. J Thorac Cardiovasc Surg 1991;102:908-12
5. Herve P, Silbert D, Cerrina J, et al. Impairment of bronchial mucociliary clearance in long term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. Chest 1993;103(1):59-63
6. Veale D, Glasper PN, Gascoigne A, et al. Ciliary beat frequency in transplanted lungs. Thorax 1993;48(6):629-31
7. Flume PA, Egan TM, Paradowski LJ, et al. Infectious complications of lung transplantation. Am J Respir Crit Care Med 1994;149:1601-7
8. Tuna IC, Jamieson SW. Human heart and lung transplantation. Adv in Surg 1989;22:251-76
9. Smyth RL, Sinclair J, Scott J, et al. Infection and reactivation with cytomegalovirus strains in lung transplant recipients. Transplantation 1991;52(3):480-82
10. Wreghitt T. Cytomegalovirus infections in heart and heart-lung transplant recipients. J Antimicrob Chemother 1989;23(Suppl E):49-60
11. Hall KA, Copeland JG, Zukoski CF, et al. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection. Transplantation 1993;55(6):1422-4
12. Hall KA, Sethi GK, Rosado LJ, et al. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993;12(3):525-6
13. Frist WH, Loyd JE, Merrill WH, et al. Single lung transplantation: a temporal look at rejection, infection, and survival. Amer Surgeon 1994;60(2)94-102
14. Dowling RD, Zenati M, Yousem SA, et al. Donor-transmitted pneumonia in experimental lung allografts: successful prevention with donor antibiotic therapy. J Thorac Cardiovas Surg 1992;103:767-72
15. Low DE, Kaiser LR, Haydock DA, et al. The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. J Thorac Cardiovas Surg 1993;106:614-21
16. Duncan AJ, Dummer JS, Paradis IL, et al. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant 1991;10:638-46
17. Pollard RB. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation. Pediatr Infect Dis J 1988;7:S97-102
18. Solans EP, Garrity ER, McCabe M, et al. Early diagnosis of cytomegalovirus pneumonitis in lung transplant patients. Arch Pathol Lab Med 1995;119(1):33-5
19. Duncan SR, Paradis IL, Yousem SA, et al. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 1992;146(6):1419-25
20. Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus infection and pneumonias. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis 1993;147(4):1017-23
21. Bando K, Paradis IL, Komatsu K, et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 1995;109(1):49-57, discussion 57-9
22. Duncan SR, Grgurich WF, Iacono AT, et al. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 1994;150(1):146-52
23. Zamora MR, Fullerton DA, Campbell DN, et al. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. Transplant Proc 1994;26(5Suppl 1):49-51
24. Gould FK, Freeman R, Taylor CE, et al. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. J Heart Lung Transplant 1993;12(4):695-9
25. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders.
26. Walker RC, Paya CV, Marshall WF, et al. Pre-transplantation seronegative Epstein-Barr virus status is the primary risk factor for post-transplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 1995;14(2):214-21
27. Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 1995;13(4):961-8
28. Ippoliti G, Martinelli L, Lorenzutti F, et al. Post-transplant lymphoproliferative disease after heart transplantation on Sandimmune therapy: treatment with interferon alfa-2b and intravenous immunoglobulin. Transplant Proc 1994;26(5):2660-1
29. Davis CL, Harrison KL, McVicar JP, et al. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Clin Transplant 1995;9(1):530-9
30. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993;16:677-88
31. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51
32. Guillemain R, Lavarde V, Amrein C, et al. Invasive aspergillosis after transplantation. Transplantation Proceedings 1995;27(1),1307-9
33. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis 1991;144:552-6
34. Levine SM, Anzueto A, Peters JI, et al. Single lung transplantation in patients with systemic disease. Chest 1994;105(3):837-41
35. Dromer C, Nashef S, Vely JF, et al. Tuberculosis in transplanted lungs. J Heart Lung Transplant 1993;924-7
36. Kramer MR, Stoehr C, Lewiston NJ, et al. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation - how effective and for how long? Transplantation 1992;53(3):586-9